Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration. - Moore AM; Nooruddin Z; Reveles KR; Koeller JM; Whitehead JM; Franklin K; Datta P; Alkadimi M; Brannman L; Cotarla I; Frankart AJ; Mulrooney T; et al. (The oncologist, 2023)